182 related articles for article (PubMed ID: 11827520)
1. Characterization of the tertiary structure of soluble CD4 bound to glycosylated full-length HIVgp120 by chemical modification of arginine residues and mass spectrometric analysis.
Hager-Braun C; Tomer KB
Biochemistry; 2002 Feb; 41(6):1759-66. PubMed ID: 11827520
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the noncovalent complex of human immunodeficiency virus glycoprotein 120 with its cellular receptor CD4 by matrix-assisted laser desorption/ionization mass spectrometry.
Borchers C; Tomer KB
Biochemistry; 1999 Sep; 38(36):11734-40. PubMed ID: 10512629
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a discontinuous epitope of the HIV envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis.
Hager-Braun C; Hochleitner EO; Gorny MK; Zolla-Pazner S; Bienstock RJ; Tomer KB
J Am Soc Mass Spectrom; 2010 Oct; 21(10):1687-98. PubMed ID: 20434359
[TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex.
Fouts TR; Tuskan R; Godfrey K; Reitz M; Hone D; Lewis GK; DeVico AL
J Virol; 2000 Dec; 74(24):11427-36. PubMed ID: 11090138
[TBL] [Abstract][Full Text] [Related]
5. Conformational rearrangement within the soluble domains of the CD4 receptor is ligand-specific.
Ashish ; Juncadella IJ; Garg R; Boone CD; Anguita J; Krueger JK
J Biol Chem; 2008 Feb; 283(5):2761-72. PubMed ID: 18045872
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
Berger EA; Lifson JD; Eiden LE
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8082-6. PubMed ID: 1896455
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells.
Zhu X; Borchers C; Bienstock RJ; Tomer KB
Biochemistry; 2000 Sep; 39(37):11194-204. PubMed ID: 10985765
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.
Dey B; Del Castillo CS; Berger EA
J Virol; 2003 Mar; 77(5):2859-65. PubMed ID: 12584309
[TBL] [Abstract][Full Text] [Related]
9. Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4.
Zhang W; Godillot AP; Wyatt R; Sodroski J; Chaiken I
Biochemistry; 2001 Feb; 40(6):1662-70. PubMed ID: 11327825
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of a highly glycosylated and unliganded gp120-based antigen using mass spectrometry.
Wang L; Qin Y; Ilchenko S; Bohon J; Shi W; Cho MW; Takamoto K; Chance MR
Biochemistry; 2010 Oct; 49(42):9032-45. PubMed ID: 20825246
[TBL] [Abstract][Full Text] [Related]
11. Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity.
Kong L; Sheppard NC; Stewart-Jones GBE; Robson CL; Chen H; Xu X; Krashias G; Bonomelli C; Scanlan CN; Kwong PD; Jeffs SA; Jones IM; Sattentau QJ
J Mol Biol; 2010 Oct; 403(1):131-147. PubMed ID: 20800070
[TBL] [Abstract][Full Text] [Related]
12. Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop.
Wang H; Cohen AA; Galimidi RP; Gristick HB; Jensen GJ; Bjorkman PJ
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7151-E7158. PubMed ID: 27799557
[TBL] [Abstract][Full Text] [Related]
13. Is the V3 loop involved in HIV binding to CD4?
Dettin M; Ferranti P; Scarinci C; Picariello G; Di Bello C
Biochemistry; 2003 Aug; 42(30):9007-12. PubMed ID: 12885233
[TBL] [Abstract][Full Text] [Related]
14. Solution structure, conformational dynamics, and CD4-induced activation in full-length, glycosylated, monomeric HIV gp120.
Guttman M; Kahn M; Garcia NK; Hu SL; Lee KK
J Virol; 2012 Aug; 86(16):8750-64. PubMed ID: 22674993
[TBL] [Abstract][Full Text] [Related]
15. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
[TBL] [Abstract][Full Text] [Related]
16. Proposed atomic structure of a truncated human immunodeficiency virus glycoprotein gp120 derived by molecular modeling: target CD4 recognition and docking mechanism.
Gabriel JL; Mitchell WM
Proc Natl Acad Sci U S A; 1993 May; 90(9):4186-90. PubMed ID: 8483933
[TBL] [Abstract][Full Text] [Related]
17. The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4 molecule.
Meiyu G; Fuchuan L; Xianliang X; Jing L; Zuowei Y; Huashi G
Antiviral Res; 2003 Jul; 59(2):127-35. PubMed ID: 12895696
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchange.
Cerutti N; Mendelow BV; Napier GB; Papathanasopoulos MA; Killick M; Khati M; Stevens W; Capovilla A
J Biol Chem; 2010 Aug; 285(33):25743-52. PubMed ID: 20538591
[TBL] [Abstract][Full Text] [Related]
19. CD4 peptide-protein conjugates, but not recombinant human CD4, bind to recombinant gp120 from the human immunodeficiency virus in the presence of serum from AIDS patients.
Ghetie V; Slaughter C; Wheeler HT; Uhr JW; Vitetta ES
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5690-3. PubMed ID: 2062847
[TBL] [Abstract][Full Text] [Related]
20. Contribution of charged amino acids in the CDR2 region of CD4 to HIV-1 gp120 binding.
Choe HR; Sodroski J
J Acquir Immune Defic Syndr (1988); 1992; 5(2):204-10. PubMed ID: 1732513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
